These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 7574788

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Efficacy of emulsion containing Gd-DTPA and lipiodol in hepatic transcatheter arterial embolization.
    Shiono T, Yoshikawa K, Hisamatsu K, Takenaka E.
    Radiat Med; 1993; 11(5):187-90. PubMed ID: 8290693
    [Abstract] [Full Text] [Related]

  • 23. Preoperative portal vein embolization for liver malignancies.
    Tarazov PG, Granov DA, Sergeev VI, Polikarpov AA, Polysalov VN, Rozengauz EV.
    Hepatogastroenterology; 2006; 53(70):566-70. PubMed ID: 16995463
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Arterial infusion of SMANCS-Lipiodol for advanced hepatocellular carcinoma].
    Miura K, Nakao N, Yoshimoto A, Yamano T, Inoue J, Takayasu Y.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():51-5. PubMed ID: 9512688
    [Abstract] [Full Text] [Related]

  • 26. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
    Hasegawa I, Hirashima N.
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
    [Abstract] [Full Text] [Related]

  • 27. [A case of hepatocellular carcinoma with tumor thrombi in the first branch of the portal vein and hepatic vein trunks treated by transcatheter hepatic arterial chemoembolization and hepatic arterial infusion chemotherapy--two years and six months follow-up].
    Haruno M, Shimamura R, Ogawa Y, Tanaka H, Sakai K, Araki K.
    Gan To Kagaku Ryoho; 2005 May; 32(5):667-70. PubMed ID: 15918569
    [Abstract] [Full Text] [Related]

  • 28. Combination of preoperative embolization of the right portal vein and hepatic artery prior to major hepatectomy in high-risk patients: a preliminary report.
    Inaba S, Takada T, Amano H, Yoshida M, Yamakawa Y, Yasuda H, Takada Y, Takeshita K, Koutake H, Takada K, Furui S, Hijikata H, Takada K.
    Hepatogastroenterology; 2000 May; 47(34):1077-81. PubMed ID: 11020883
    [Abstract] [Full Text] [Related]

  • 29. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK, Wikström M, Flechtenmacher C, Filser T, Dueber C.
    Cardiovasc Intervent Radiol; 2006 May; 29(5):778-84. PubMed ID: 16779690
    [Abstract] [Full Text] [Related]

  • 30. [A long-term survival of the patient with hepatocellular carcinoma and advanced portal vein and bile duct tumor thrombosis successfully treated with multimodal treatments].
    Tashima R, Beppu T, Nakagawa M, Ishiko T, Sugiyama S, Suyama K, Masuda T, Hirota M, Kanemitsu K, Okabe K, Yamanaka T, Sasaki Y, Baba H.
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1805-8. PubMed ID: 16315947
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils.
    Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, Wallace MJ, Morello FA, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey JN.
    J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):215-25. PubMed ID: 15713922
    [Abstract] [Full Text] [Related]

  • 33. Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility.
    Nagino M, Kamiya J, Kanai M, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Nimura Y.
    Surgery; 2000 Feb; 127(2):155-60. PubMed ID: 10686980
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [A case report of hepatocellular carcinoma with hepatic and portal venous tumor thrombus and multiple intrahepatic metastasis who survived over 1 year after the operation with combined locoregional chemotherapy].
    Shimizu J, Nagano H, Sakon M, Dono K, Takeda Y, Kishimoto S, Eguchi H, Miyamoto A, Kondo M, Nakamori S, Umeshita K, Nakamura H, Wakasa K, Monden M.
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1895-9. PubMed ID: 10560420
    [Abstract] [Full Text] [Related]

  • 36. Hepatocellular carcinoma invading the main portal vein: treatment with transcatheter arterial chemoembolization and portal vein stenting.
    Zhang XB, Wang JH, Yan ZP, Qian S, Liu R.
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):52-61. PubMed ID: 18931871
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
    Eguchi S, Matsumoto S, Hamasaki K, Takatsuki M, Hidaka M, Tajima Y, Sakamoto I, Kanematsu T.
    J Hepatobiliary Pancreat Surg; 2008 Jan; 15(6):627-33. PubMed ID: 18987934
    [Abstract] [Full Text] [Related]

  • 40. [A case of long-term survival with TAE resistant multiple recurrence HCC successfully treated by hepatic resection].
    Nakamura M, Nagano H, Sakon M, Yamamoto T, Ota H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Hiramatsu N, Hayashi N, Monden M.
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1717-21. PubMed ID: 14619502
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.